PHAXIAM Therapeutics S.A.
PHXM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23 | -$0 | -$54 | -$73 |
| Dep. & Amort. | $2 | $3 | $5 | $5 |
| Deferred Tax | -$0 | $1 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $1 | $1 |
| Change in WC | -$2 | -$8 | -$7 | $11 |
| Other Non-Cash | -$0 | -$27 | -$3 | $5 |
| Operating Cash Flow | -$24 | -$32 | -$57 | -$52 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $38 | $0 | $0 |
| Inv. Purchases | -$0 | -$0 | -$0 | -$0 |
| Inv. Sales/Matur. | $0 | $1 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $38 | -$0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $35 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$2 | $45 | $25 |
| Financing Cash Flow | -$4 | -$2 | $45 | $25 |
| Forex Effect | $0 | $0 | $2 | -$1 |
| Net Chg. in Cash | -$28 | $5 | -$11 | -$29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39 | $34 | $44 | $73 |
| End Cash | $10 | $39 | $34 | $44 |
| Free Cash Flow | -$25 | -$32 | -$57 | -$53 |